button_search2

Tumor

Disclaimer
Copyright 2007
Eigenbrodt / Mazurek
Webdesign and
Webserver by
onSite

Tumor M2-PK:

a tool for metabolic profiling of gastric cancer

Comparison of sensitivities of Tumor M2-PK, CEA, CA19-9 and CA 72.4 in gastric tumors

nm = non metastasized; m = metastasized; t = total
n.d.a. = no data available

gastriccancer

Sensitivities for combination of Tumor M2-PK with classical tumor markers

Schulze, 2000:    Tumor M2-PK + Ca 72-4:     82 %

Tumor M2-PK concentrations were measured with a sandwich ELISA from
ScheBo • Biotech AG, Giessen, Germany.

CEA, CA-19-9 and CA 72-4 were determined using, Cobras Core II from Roche Diagnostics, Mannheim, enzymun Test-ES 600 Immunology Multianalyzer as well as tests from Sorin Diagnostics, Saluggia.

References

Tumor M2-PK: clinical relevance for metabolic profiling of tumors

Metabolic tools for tumor diagnosis

Pyruvate kinase isoenzymes: M2-PK

[Home] [Overview] [Glycolysis] [Glutaminolysis] [Nucleogenesis] [Serinolysis] [Lipogenesis] [tumor_metabolome_key_metabolites] [Nutrients] [Oncoproteins] [tumor_diagnosis] [Animations]